Previous Article | Next Article 
Journal of Virology, April 2005, p. 5000-5005, Vol. 79, No. 8
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.8.5000-5005.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine Design
Marcus Altfeld,1*
Todd M. Allen,1
Elizabeth T. Kalife,1
Nicole Frahm,1
Marylyn M. Addo,1
Bianca R. Mothe,2
Almas Rathod,1
Laura L. Reyor,1
Jason Harlow,1
Xu G. Yu,1
Beth Perkins,1
Loren K. Robinson,1
John Sidney,3
Galit Alter,1
Mathias Lichterfeld,1
Alessandro Sette,3
Eric S. Rosenberg,1
Philip J. R. Goulder,1,4
Christian Brander,1 and
Bruce D. Walker1,5
Partners AIDS Research Center, Massachusetts General Hospital, and Division of AIDS, Harvard Medical School, Boston, Massachusetts,1
Howard Hughes Medical Institute,5
La Jolla Institute for Allergy and Immunology, San Diego,3
Department of Biological Sciences, California State University; San Marcos, California,2
Department of Pediatrics, Nuffield Department of Medicine, Oxford, United Kingdom4
Received 1 October 2004/
Accepted 2 December 2004
Human immunodeficiency virus type 1 (HIV-1) mutates to escape immune selection pressure, but there is little evidence of selection mediated through HLA-A2, the dominant class I allele in persons infected with clade B virus. Moreover, HLA-A2-restricted responses are largely absent in the acute phase of infection as the viral load is being reduced, suggesting that circulating viruses may lack immunodominant epitopes targeted through HLA-A2. Here we demonstrate an A2-restricted epitope within Vpr (Vpr59-67) that is targeted by acute-phase HIV-1-specific CD8+ T cells, but only in a subset of persons expressing HLA-A2. Individuals in the acute stage of infection with viruses containing the most common current sequence within this epitope (consensus sequence) were unable to mount epitope-specific T-cell responses, whereas subjects infected with the less frequent I60L variant all developed these responses. The I60L variant epitope was a stronger binder to HLA-A2 and was recognized by epitope-specific T cells at lower peptide concentrations than the consensus sequence epitope. These data demonstrate that HLA-A2 is capable of contributing to the acute-phase cytotoxic T-lymphocyte response in infected subjects, but that most currently circulating viruses lack a dominant immunogenic epitope presented by this allele, and suggest that immunodominant epitopes restricted by common HLA alleles may be lost as the epidemic matures.
* Corresponding author. Mailing address: Partners AIDS Research Center, Massachusetts General Hospital, 149 13th St., Boston, MA 02129. Phone: (617) 724-2461. Fax: (617) 724-8586. E-mail:
maltfeld{at}partners.org.
Journal of Virology, April 2005, p. 5000-5005, Vol. 79, No. 8
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.8.5000-5005.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Miura, T., Brockman, M. A., Brumme, Z. L., Brumme, C. J., Pereyra, F., Trocha, A., Block, B. L., Schneidewind, A., Allen, T. M., Heckerman, D., Walker, B. D.
(2009). HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1. J. Virol.
83: 140-149
[Abstract]
[Full Text]
-
Rousseau, C. M., Daniels, M. G., Carlson, J. M., Kadie, C., Crawford, H., Prendergast, A., Matthews, P., Payne, R., Rolland, M., Raugi, D. N., Maust, B. S., Learn, G. H., Nickle, D. C., Coovadia, H., Ndung'u, T., Frahm, N., Brander, C., Walker, B. D., Goulder, P. J. R., Bhattacharya, T., Heckerman, D. E., Korber, B. T., Mullins, J. I.
(2008). HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load. J. Virol.
82: 6434-6446
[Abstract]
[Full Text]
-
Neumann-Haefelin, C., Frick, D. N., Wang, J. J., Pybus, O. G., Salloum, S., Narula, G. S., Eckart, A., Biezynski, A., Eiermann, T., Klenerman, P., Viazov, S., Roggendorf, M., Thimme, R., Reiser, M., Timm, J.
(2008). Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level. J. Virol.
82: 3438-3451
[Abstract]
[Full Text]
-
Karlsson, A. C., Chapman, J. M., Heiken, B. D., Hoh, R., Kallas, E. G., Martin, J. N., Hecht, F. M., Deeks, S. G., Nixon, D. F.
(2007). Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol. J. Virol.
81: 11543-11548
[Abstract]
[Full Text]
-
Schaubert, K. L., Price, D. A., Frahm, N., Li, J., Ng, H. L., Joseph, A., Paul, E., Majumder, B., Ayyavoo, V., Gostick, E., Adams, S., Marincola, F. M., Sewell, A. K., Altfeld, M., Brenchley, J. M., Douek, D. C., Yang, O. O., Brander, C., Goldstein, H., Kan-Mitchell, J.
(2007). Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419-27 Epitope. J. Immunol.
178: 7756-7766
[Abstract]
[Full Text]
-
Li, B., Gladden, A. D., Altfeld, M., Kaldor, J. M., Cooper, D. A., Kelleher, A. D., Allen, T. M.
(2007). Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution. J. Virol.
81: 193-201
[Abstract]
[Full Text]
-
Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T., Sango, K., Hewitt, H. S., Henry, L., Linde, C. H., Chisholm, J. V. III, Zaman, T. M., Pae, E., Mallal, S., Walker, B. D., Sette, A., Korber, B. T., Heckerman, D., Brander, C.
(2006). Impact of HLA-B Alleles, Epitope Binding Affinity, Functional Avidity, and Viral Coinfection on the Immunodominance of Virus-Specific CTL Responses. J. Immunol.
176: 4094-4101
[Abstract]
[Full Text]
-
Bowen, D. G., Walker, C. M.
(2005). Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. JEM
201: 1709-1714
[Abstract]
[Full Text]